Details for New Drug Application (NDA): 017434
✉ Email this page to a colleague
The generic ingredient in PROSTIN F2 ALPHA is dinoprost tromethamine. There are six drug master file entries for this compound. Additional details are available on the dinoprost tromethamine profile page.
Summary for 017434
Tradename: | PROSTIN F2 ALPHA |
Applicant: | Pharmacia And Upjohn |
Ingredient: | dinoprost tromethamine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017434
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 5MG BASE/ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017434
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pharmacia And Upjohn | PROSTIN F2 ALPHA | dinoprost tromethamine | INJECTABLE;INJECTION | 017434-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription